Intracardiac and extracardiac markers of inflammation during atrial fibrillation

Heart Rhythm

Volumn 7, Issue 2, 2010, Pages 149-154

  Marcus, Gregory M ^a   Smith, Lisa M ^a   Ordovas, Karen ^a   Scheinman, Melvin M ^a   Kim, Albert M ^a   Badhwar, Nitish ^a   Lee, Randall J ^a   Tseng, Zian H ^a   Lee, Byron K ^a   Olgin, Jeffrey E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial fibrillation; C reactive protein; Coronary sinus; Inflammation; Interleukin 6; Left atrium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD SAMPLING; CARDITIS; CASE CONTROL STUDY; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORONARY SINUS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; STATISTICAL SIGNIFICANCE;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 74449090886     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.10.004     Document Type: Article

References (25)

1. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
2. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
3. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
4. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
5. Marcus G.M., Whooley M.A., Glidden D.V., Pawlikowska L., Zaroff J.G., and Olgin J.E. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J 155 (2008) 303-309
6. Kallergis E.M., Manios E.G., Kanoupakis E.M., et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart 94 (2008) 200-204
7. Marcus G.M., Smith L.M., Glidden D.V., et al. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm 5 (2008) 215-221
8. Dittrich H.C., Pearce L.A., Asinger R.W., et al. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 137 (1999) 494-499
9. Kourliouros A., Savelieva I., Kiotsekoglou A., Jahangiri M., and Camm J. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 157 (2009) 243-252
10. Yao S.Y., Chu J.M., Chen K.P., et al. Inflammation in lone atrial fibrillation. Clin Cardiol 32 (2009) 94-98
11. Shah S.J., Marcus G.M., Gerber I.L., et al. High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail 12 (2006) 61-65
12. Liuba I., Ahlmroth H., Jonasson L., et al. Source of inflammatory markers in patients with atrial fibrillation. Europace 10 (2008) 848-853
13. Singh U., Devaraj S., and Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem 55 (2009) 361-364
14. Nagaoka T., Kuo L., Ren Y., Yoshida A., and Hein T.W. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 49 (2008) 2053-2060
15. Liuzzo G., Santamaria M., Biasucci L.M., et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 49 (2007) 185-194
16. Singh U., Devaraj S., Dasu M.R., Ciobanu D., Reusch J., and Jialal I. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol 26 (2006) 2469-2475
17. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
18. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
19. Birks E.J., Burton P.B., Owen V., et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 (2000) III352-III358
20. Janssen S.P., Gayan-Ramirez G., Van den Bergh A., et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111 (2005) 996-1005
21. Psychari S.N., Apostolou T.S., Sinos L., Hamodraka E., Liakos G., and Kremastinos D.T. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95 (2005) 764-767
22. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
23. Corradi D., Callegari S., Maestri R., Benussi S., and Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med 5 (2008) 782-796
24. Page P.L., Plumb V.J., Okumura K., and Waldo A.L. A new animal model of atrial flutter. J Am Coll Cardiol 8 (1986) 872-879
25. Gaudino M., Andreotti F., Zamparelli R., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 Suppl 1 (2003) II195-II199